17 research outputs found
Archaeal lipids in Mediterranean cold seeps: molecular proxies for anaerobic methane oxidation
We investigated the distributions and 13C values of biomarkers for Archaea associated with anaerobic methane oxidation in disparate settings throughout two Eastern Mediterranean mud dome fields. All major classes of archaeal lipids are present in the studied sediments, including isoprenoid glycerol diethers, isoprenoid glycerol dialkyl glycerol tetraethers, and irregular isoprenoid hydrocarbons. Of the compounds present, many, including a novel glycerol tetraether and sn-3-hydroxyarchaeol, have not been previously reported for settings in which methane oxidation is presumed to occur. Archaeal lipids are depleted in 13C, indicating that the Archaea from which they derive are either directly or indirectly involved with methane consumption. The most widespread archaeal lipids are archaeol, PMI, and glycerol tetraethers, and these compounds are present at all active sites. However, archaeal lipid abundances and distributions are highly variable; ratios of crocetane, PMI, and hydroxyarchaeol relative to archaeol vary from 0 to 6.5, from 0 to 2, and from 0 to 1, respectively. These results suggest that archaeal communities differ amongst the sites examined. In addition, carbon isotopic variability amongst archaeal biomarkers in a given mud breccia can be as large as 24 , suggesting that even at single sites multiple archaeal species perform or are supported by anaerobic methane oxidation
Een theoretische methode ter bepaling van de procescondities voor optimale sterilisatie van verpakte voedingsmiddelen met een verhittings- en koelmedium op constante temperatuur
The herpes simplex virus type 1 UL37 gene product is a component of virus particles
The herpes simplex virus type 1 UL37 gene encodes a
protein with an Mr of 120K that is produced at late times
after infection. To study the properties of this protein we
have linked a 10 amino acid epitope derived from a
human cytomegalovirus protein to the UL37 polypeptide
coding sequences by inserting an oligonucleotide at a
SpeI site that is unique in the virus genome and lies close
to the 3' end of the open reading frame. From studies on
the resultant virus recombinant using a monoclonal
antibody that recognizes the inserted epitope we find
that, contrary to a previous report, the UL37 protein is
a structural component of both virions and L particles
and is present in the tegument of virus particles. Indirect
immunofluorescence analysis revealed that the protein is
distributed throughout infected cells but is more abundant
in the cytoplasm than the nucleus
Shortâcut method for the calculation of sterilization conditions yielding optimum quality retention for conductionâtype heating of packaged foods
Based on analytical equations for the temperature distribution history in a container, the relation between the reductions of the concentrations of heat labile food components, including microorganisms. nutrients and sensory factors, and the kinetic parameters of the reactions causing these reductions, has been calculated numerically. For a constant temperature of the heating medium with time it is concluded that the loss of quality is almost minimal at one Fourier value of the heating time. This optimal Fourier value is a function of only the Biot number and the relationship between initial product temperature, cooling water temperature and retort temperature. At an infinite value of Biot and a cooling water temperature equal to the initial product temperature the optimum Fourier value amounts to 0.5. On the basis of this conclusion a shortâcut calculation method is developed. The method is valid for Biot numbers larger than 10, initial homogeneous product temperatures equal to or larger than the temperature of the cooling medium and for the main container geometries including spheres, cylinders and rectangular bodies. The method does not require tedious interpolations of tables. The calculation of the optimum process conditions to obtain the desired sterility and the calculation of the retention of the quality factor of interest require only a few minutes on a pocket calculator. For routine calculations the procedure can conveniently be programmed
Vaccination of MDA positive pigs with a live modified PRRSV vaccine
Since it emerged,
PRRSV has had an important economic impact on the swine industry. Proper
vaccination against PRRSV can significantly improve the production results in feeder
finishing pigs. Ideally, fattening pigs are vaccinated at 6 weeks of age,
when no maternally derived antibodies (MDA) are present anymore. However, when there is a
high PRRSV wild-type pressure, it might be beneficial to vaccinate earlier.
In this study, we investigated how antibodies influence vaccination with a modified PRRSV
vaccine. To examine the effect of antibodies on the vaccine take, four
groups of approximately 50 pigs each were vaccinated at 3 to 4 weeks of age with Porcilis
PRRS (Intervet Int. b.v., Boxmeer, The Netherlands). At this period,
various levels of PRRSV specific antibody titres were found. One group was vaccinated
intradermally with 1 dose of Porcilis PRRS and 3 groups were vaccinated
intramuscularly with 0.1, 1 and 10 doses of Porcilis PRRS, respectively. One group of 10 pigs
was left unvaccinated. Blood was taken at various weeks post vaccination.
PRRSV specific immunofluorescence test (IFT) antibody titres were determined from all samples
and PRRSV neutralising antibody titres only from the samples taken at
vaccination. Based on these data, it could be determined whether or not a pig seroconverted
by vaccination and whether the vaccine had taken or not. To determine
the effect of the antibody titres on vaccine take, all pigs were categorised according to
their overall MDA titre and their PRRSV neutralising antibody titre at
vaccination. Then the percentage of seroconverted animals per category was calculated.
Regardless of the dose and route, 65% or more of the pigs seroconverted
by vaccination, a percentage high enough to give sufficient herd protection. No consistent
relation could be found between the virus neutralising (VN)-titres and
the percentages of takes. When the effect of the total antibody titre on vaccine take was
evaluated, high MDA titres were correlated with a high percentage of takes.
At medium titres, the least number of takes were found. When the titres further decreased the
percentage of takes again increased. We interpreted that these parabolic
curves were the resultant of the positive effects of the opsonising PRRSV specific antibodies
and the negative effects of PRRSV neutralising antibodies on vaccine take.
Basically the virus can use two independent routes to enter its target cell, the macrophage.
First, it can use the PRRSV specific receptor. Alternatively, in the presence
of PRRSV specific antibodies, it can enter by the Fc-receptors on the macrophage. However,
the influence of antibodies is opposite in both routes: high antibody levels
will facilitate a better uptake of the virus by the Fc-receptors but will inhibit the uptake
of the virus in the macrophage by the PRRSV specific receptors. At low antibody
titres, the reverse situation occurs: virus uptake by the receptors is enhanced and uptake by
the Fc-receptors is minimised. With this mechanism, the lowest percentage of
takes will be obtained at medium antibody titres. High percentages of takes will be found at
either high antibody titres, facilitating a good uptake by the Fc-receptor,
or at low antibody titres, facilitating a good uptake by the PRRSV specific receptor. Because
of the opsonisation of the virus by PRRSV specific antibodies, it will be
possible to vaccinate young, MDA positive piglets